Unity Biotechnology Q2 EPS $(0.32) Up From $(0.38) YoY
Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.32) per share. This is a 15.79 percent increase over losses of $(0.38) per share from the same period last year.
Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.32) per share. This is a 15.79 percent increase over losses of $(0.38) per share from the same period last year.